Skip to main content
RECOVAC Consortium on Muck Rack

RECOVAC Consortium

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with RECOVAC

Contact RECOVAC, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity - npj Vaccines

|
By Yvette den Hartog, Carla C. Baan, RECOVAC Consortium
| Nature Verified
Abstract Healthy individuals with hybrid immunity, due to a SARS-CoV-2 infection prior to first vaccination, have stronger immune responses compared to those who were exclusively vaccinated. However, little is known about the characteristics of antibody, B- and T-cell responses in kidney disease patients with hybrid immunity. Here, we explored differences between kidney disease patients and controls with hybrid immunity after asymptomatic or mild coronavirus disease-2019 (COVID-19).
Open in Who Shared Issue with article?
See all 1 articles